Novartis AG
NVS
#54
Rank
$299.439 B
Marketcap
Switzerland
Country
$157.54
Share price
1.90%
Change (1 day)
10.76%
Change (1 year)
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy…
Key Metrics
Trailing P/E
20.76
Forward P/E
14.03
EPS (TTM)
$6.63
Forward EPS
$9.84
Price / Book
6.30
EV / EBITDA
13.1x
Beta
0.49
Dividend Yield
3.45%
Return on Equity
30.35%
Return on Assets
10.25%
Debt / Equity
116.85
Current Ratio
0.86
Gross Margin
74.98%
Operating Margin
34.62%
Net Profit Margin
22.50%
Free Cash Flow
$11.900B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 12 – Sep 11
-9.65%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$56.674B
Latest Net Income$13.984B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Novartis AG with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
NVS
No recent news available. Set FINNHUB_API_KEY to enable news.
